A Rare Case Of Severe COVID-19 Progressing To Secondary WEST Syndrome: A Case Report
- byDoctor News Daily Team
- 25 July, 2025
- 0 Comments
- 0 Mins
Dr.Mallesh and his colleagues from Department of Pediatrics, Bangalore Medical college, Karnataka report an interesting case of severe COVID-19 and dengue infection presenting as ALERD(acute leucoencephalopathy with radiological diagnosis) progressing to WEST syndrome at follow-up.
A five month old infant presented with history of fever for past 5 days and altered sensorium with refusal of feeds on day 3 of illness. Infant was treated for severe dengue as supported by positive ELISA on day 5 of illness.
On day 10 of illness, child had hepatomegaly, ascites and bilateral infiltrates on chest X-ray, hence RTPCR of nasopharyngeal swab was done and tested positive for SARS-CoV2. MRI brain done in view of altered sensorium revealing diffusion restriction and edematous changes in sub-cortical white matter, hence a suspicion of acute demyelinating encephalomyelitis (ADEM).
Blood investigations showed anemia, thrombocytopenia, deranged liver enzymes and elevated CRP and procalcitonin. Infant met the criteria for cytokine storm as evidenced by elevated D-dimer, serum ferritin, serum LDH and IL-6.
Intravenous methylprednisolone 20 mg/kg/day was added for 5 days under the cover of antibiotics with pending culture reports as to tackle dual dilemma of suspected ADEM and Cytokine storm. On day 12 of illness infant threw 3 episodes of afebrile motor seizures requiring phenytoin and levetericetam. Following 5 days of IV steroid therapy, baby's sensorium improved with downward trend of inflammatory markers. Hence child was given 14 days of oral steroid followed by tapering dose. Repeat testing for SARS-CoV2 RTPCR was negative. Baby started taking breastfeeding on demand by day 20 of illness ,hence discharged on oral steroids along with levetericetam.
At follow up child had delayed motor development, with loss of previous attained milestones and repeat MRI brain showed clearing of previous lesions. BERA and VEP were normal for age. Over the next course of 5 months child had she developed repeated episodes of epileptic spasms with Electroencephalogram (EEG) features of hypsarrhthymia hence a diagnosis of West syndrome post encephalopathy was made in her. As child is on oral steroids and levetericetam with partially controlled symptoms, further treatment with adrenocorticotrophic hormone therapy (ACTH) to be considered.
Reviewing the course of illness, hypercytokinemia, typical MRI features of bright tree appearance on Diffusion weighted image (DWI) and follow-up MRI resolution, with post-encephalopathic sequelae of West syndrome, ADEM was superseded by its differential— acute leucoencephalopathy with restricted diffusion (ALERD) as the primary diagnosis in this child.
ALERD is a newly emerging clinical-radiological syndrome seen in children with post-infectious encephalopathy, needs to be differentiated from ADEM; may be a neurological complication of COVID-19 both of which cause hypercytokinemia.
In dengue endemic countries like India, coinfection with SARS-CoV2 poses a challenge in diagnosis and treatment as initial symptoms overlap with nearly identical lab parameters.
Author concludes-" All cases of documented dengue fever with shock and/or altered sensorium need to be tested for COVID-19, especially in this time of pandemic."
Source: Journal of Tropical Pediatrics
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
DME Gujarat extends PG Ayurveda, Homeopathy round...
- 05 November, 2025
NEET counselling: CENTAC publishes round 3 provisi...
- 05 November, 2025
Marksans Pharma UK arm gets marketing nod for Exem...
- 05 November, 2025
Zydus Wellness net sales up by 31 percent in Q2 FY...
- 05 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!